CDH1 and cancer: Over the past decade, a number of studies have demonstrated that many CAMs are overexpressed in chemotherapy-resistant cancer cells, whereas some CAMs, such as integrin α2β1, CD31 and E-cadherin under expressed in cancer cells [16,194].